MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
Rhea-AI Summary
eXeX, a Surgery Intelligence company, appointed Max Reinhardt as President, Healthcare, to lead commercial execution of its Canopus platform across hospital systems in the United States, the United Kingdom and other markets. Reinhardt brings more than three decades of MedTech and pharmaceutical leadership, including 17 years at Johnson & Johnson and President-level roles at Orthofix Medical (NASDAQ: OFIX), Pacira BioSciences and DePuy Synthes.
Canopus by eXeX is described as the first Surgery Intelligence platform, delivering OR-, surgeon- and procedure-specific setup and step-by-step execution plans in real time using touch-free technology, without EHR integration or patient data. According to eXeX, the system aims to reduce surgeon cognitive load, support OR teamwork and improve OR productivity, and is already deployed across multiple hospital groups in the US and UK, having supported several thousand live surgeries, initially in complex spine and orthopedics.
eXeX also introduced Canopus Command, an intelligent portal giving hospital staff and leadership a live operational view into every surgical case, exposing real-time metrics such as setup accuracy, workflow timing, supply utilization and onboarding velocity. A key metric in Canopus Command is the “Surgical Inquiry” – the moment a team member pulls the exact information needed for the case – which can be tracked across facilities to show where information demand is concentrating by procedure, team and workflow stage, enabling leadership to allocate resources ahead of need. Reinhardt joins recently appointed COO John Spranger and Chairman/CEO Dr. Robert Masson to drive the company’s stated goal of bringing Canopus to every OR, for every surgeon and every surgery.
Positive
- None.
Negative
- None.
News Market Reaction – OFIX
In the Jul 21 session, OFIX gained 0.61%, reflecting a mild positive market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 15 | Earnings date notice | Neutral | +3.1% | Scheduled second-quarter results release and conference call for August 5 |
| May 18 | Investor conferences | Neutral | +1.1% | Participation announced for two June healthcare investor conferences |
| May 06 | Product portfolio update | Positive | -2.0% | FITBONE system launch and OrthoNext software enhancements were announced |
| May 05 | First-quarter earnings | Positive | +3.6% | Quarterly results reported and full-year financial guidance reaffirmed |
| Apr 21 | Earnings date notice | Neutral | -4.3% | First-quarter results release and conference call were scheduled for May 5 |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive earnings updates were followed by gains, while the product-update announcement was followed by a decline.
Key Terms
cognitive load medical
ehr integration technical
craniomaxillofacial medical
biologics medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in
Canopus™ by eXeX is the world's first Surgery Intelligence platform, designed to transform the experience in the Operating Room (OR) by presenting surgeon, surgery, and OR-specific setup and step-by-step procedure execution plans in real time. Canopus utilizes touch-free technology, digitizing the experience and knowledge of the most capable teams for every OR, every surgeon, and every surgery. The solution reduces surgeon cognitive load, facilitates effective OR teamwork, enables improved OR productivity, and is non-clinical by design, requiring no EHR integration and excluding any patient data for ease of adoption. Canopus optimizes preparation, orchestrates the OR in real time, and turns every case into a planned, structured, informed operation, with the ability for the team to continually optimize the plan as required at any time.
The appointment caps a period of accelerated quarter-over-quarter growth. Canopus is deployed across multiple hospital groups in
"The operating room is the most complex workspace on Earth. It deserves intelligent infrastructure, and it deserves leaders who have lived inside it," said Robert Masson, MD, Chairman and CEO of eXeX and a practicing neurological spine surgeon. "Max has spent three decades putting the world's most advanced surgical technology into the hands of teams on every continent. There is no better person to lead our commercial efforts at this exciting time."
A Career Built in the Operating Room
Reinhardt brings more than three decades of global MedTech and pharmaceutical executive leadership experience, including seventeen years with Johnson & Johnson. He started with J&J at DePuy Spine in the
- President, Global Spine, Orthofix Medical (NASDAQ: OFIX), 2024: leading the company's global spine and biologics business
- President, Pacira BioSciences 2019: overseeing all commercial and medical affairs
- Worldwide President, DePuy Synthes Spine (the spine division of Johnson & Johnson) 2013: driving the business to the number-two market-share position in the global spine market
- Worldwide President, Joint Reconstruction, Sports Medicine & Power Tools, DePuy Synthes, a Johnson & Johnson company
Earlier in his career, Reinhardt held senior leadership positions with Steris and Olympus in
"I have spent thirty years bringing innovation to surgeons and operating rooms globally. eXeX is transforming one of the most complex and demanding work environments - the OR, where planning, communication, teamwork and execution are vital to a great outcome," said Reinhardt. "The best surgical teams in the world run on memory and tribal knowledge. For the first time, that experience and know-how can be captured and delivered, making every case the team's best case. This is a once-in-a-generation shift that is long overdue, and eXeX is leading it."
Reinhardt joins recently appointed Chief Operating Officer John Spranger to form the leadership team driving Surgery Intelligence. Alongside Dr. Masson, their mandate is to bring Canopus by eXeX to every OR, for every surgeon and every surgery.
eXeX Launches Canopus Command
eXeX also announced Canopus Command, an intelligent portal that gives hospital staff and leadership a live operational view inside every case. Every procedure generates operational data (setup accuracy, workflow timing, supply utilization, onboarding velocity) that until now disappeared the moment the case ended. With Canopus Command, hospitals see it in real time.
At its heart is a breakthrough measurement: the Surgical Inquiry, the discrete moment a team member pulls the exact information they need for the case in front of them. Tracked across a facility, Surgical Inquiries reveal where demand is concentrating (by procedure, by team, and by moment in the workflow) so leadership can move resources and personnel ahead of the need, not after it.
About eXeX
eXeX (Expanded Existence, Inc.) is building the operating system for surgery. Founded in 2022 and headquartered in Orlando, Florida, the company has built a patented platform, Canopus by eXeX, that is live across hospital systems in the United States and United Kingdom and expanding worldwide, providing surgical teams with workflow guidance and giving hospital leadership real-time operational visibility into every case. Learn more at exex.ai.
Media Contact
Douglas Sonders
douglas@exex.ai • 703-618-4110
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtech-pioneer-max-reinhardt-joins-exex-to-drive-canopus-platform-growth-302830852.html
SOURCE eXeX